These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26358404)

  • 1. Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer.
    de Voer RM; Hahn MM; Mensenkamp AR; Hoischen A; Gilissen C; Henkes A; Spruijt L; van Zelst-Stams WA; Kets CM; Verwiel ET; Nagtegaal ID; Schackert HK; van Kessel AG; Hoogerbrugge N; Ligtenberg MJ; Kuiper RP
    Sci Rep; 2015 Sep; 5():14060. PubMed ID: 26358404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer and polymorphisms in DNA repair genes WRN, RMI1 and BLM.
    Frank B; Hoffmeister M; Klopp N; Illig T; Chang-Claude J; Brenner H
    Carcinogenesis; 2010 Mar; 31(3):442-5. PubMed ID: 19945966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal and Endometrial Cancer Risk and Age at Diagnosis in BLMAsh Mutation Carriers.
    Schayek H; Laitman Y; Katz LH; Pras E; Ries-Levavi L; Barak F; Friedman E
    Isr Med Assoc J; 2017 Jun; 19(6):365-367. PubMed ID: 28647934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline BLM mutations and metastatic prostate cancer.
    Ledet EM; Antonarakis ES; Isaacs WB; Lotan TL; Pritchard C; Sartor AO
    Prostate; 2020 Feb; 80(2):235-237. PubMed ID: 31816118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study.
    Balaguer F; Castellví-Bel S; Castells A; Andreu M; Muñoz J; Gisbert JP; Llor X; Jover R; de Cid R; Gonzalo V; Bessa X; Xicola RM; Pons E; Alenda C; Payá A; Piqué JM;
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):379-87. PubMed ID: 17368238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common nonsense mutation of the BLM gene and prostate cancer risk and survival.
    Antczak A; Kluźniak W; Wokołorczyk D; Kashyap A; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Masojć B; Górski B; Gromowski T; Nagorna A; Gołąb A; Sikorski A; Słojewski M; Gliniewicz B; Borkowski T; Borkowski A; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Domagała P; Stawicka M; Milecki P; Akbari MR; Narod SA; Lubiński J; Cybulski C; ; ; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała W; Chosia M; van de Wetering T; Serrano-Fernández P; Puszyński M; Soczawa M; Switała J; Archimowicz S; Kordowski M; Zyczkowski M; Borówka A; Bagińska J; Krajka K; Szwiec M; Haus O; Janiszewska H; Stembalska A; Sąsiadek MM
    Gene; 2013 Dec; 532(2):173-6. PubMed ID: 24096176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygosity for the BLM(Ash) mutation and cancer risk.
    Cleary SP; Zhang W; Di Nicola N; Aronson M; Aube J; Steinman A; Haddad R; Redston M; Gallinger S; Narod SA; Gryfe R
    Cancer Res; 2003 Apr; 63(8):1769-71. PubMed ID: 12702560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer.
    Bellido F; Sowada N; Mur P; Lázaro C; Pons T; Valdés-Mas R; Pineda M; Aiza G; Iglesias S; Soto JL; Urioste M; Caldés T; Balbín M; Blay P; Rueda D; Durán M; Valencia A; Moreno V; Brunet J; Blanco I; Navarro M; Calin GA; Borck G; Puente XS; Capellá G; Valle L
    Gastroenterology; 2018 Jan; 154(1):181-194.e20. PubMed ID: 28912018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical implications of germline mutations in breast cancer genes: RECQL.
    Bowden AR; Tischkowitz M
    Breast Cancer Res Treat; 2019 Apr; 174(3):553-560. PubMed ID: 30610487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Candidate colorectal cancer predisposing gene variants in Chinese early-onset and familial cases.
    Zhang JX; Fu L; de Voer RM; Hahn MM; Jin P; Lv CX; Verwiel ET; Ligtenberg MJ; Hoogerbrugge N; Kuiper RP; Sheng JQ; Geurts van Kessel A
    World J Gastroenterol; 2015 Apr; 21(14):4136-49. PubMed ID: 25892863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk for developing cancer in Israeli ATM, BLM, and FANCC heterozygous mutation carriers.
    Laitman Y; Boker-Keinan L; Berkenstadt M; Liphsitz I; Weissglas-Volkov D; Ries-Levavi L; Sarouk I; Pras E; Friedman E
    Cancer Genet; 2016 Mar; 209(3):70-4. PubMed ID: 26778106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterozygous germline
    Bononi A; Goto K; Ak G; Yoshikawa Y; Emi M; Pastorino S; Carparelli L; Ferro A; Nasu M; Kim JH; Suarez JS; Xu R; Tanji M; Takinishi Y; Minaai M; Novelli F; Pagano I; Gaudino G; Pass HI; Groden J; Grzymski JJ; Metintas M; Akarsu M; Morrow B; Hassan R; Yang H; Carbone M
    Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33466-33473. PubMed ID: 33318203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms.
    Zauber NP; Sabbath-Solitare M; Marotta S; Zauber AG; Foulkes W; Chan M; Turner F; Bishop DT
    Cancer; 2005 Aug; 104(4):719-29. PubMed ID: 15959913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of germline mutations in the spindle assembly checkpoint gene BUB1B in individuals with early-onset colorectal cancer.
    Hahn MM; Vreede L; Bemelmans SA; van der Looij E; van Kessel AG; Schackert HK; Ligtenberg MJ; Hoogerbrugge N; Kuiper RP; de Voer RM
    Genes Chromosomes Cancer; 2016 Nov; 55(11):855-63. PubMed ID: 27239782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole exome sequencing and single nucleotide polymorphism array analyses to identify germline alterations in genes associated with testosterone metabolism in a patient with androgen insensitivity syndrome and early-onset colorectal cancer.
    Disciglio V; Devecchi A; Palumbo O; Carella M; Penso D; Milione M; Valle G; Pierotti MA; Vitellaro M; Bertario L; Canevari S; Signoroni S; De Cecco L
    Chin J Cancer; 2016 Jun; 35(1):51. PubMed ID: 27267075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of breast and colorectal cancer in Ashkenazi Jewish carriers of Fanconi anemia and Bloom syndrome.
    Baris HN; Kedar I; Halpern GJ; Shohat T; Magal N; Ludman MD; Shohat M
    Isr Med Assoc J; 2007 Dec; 9(12):847-50. PubMed ID: 18210922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.
    Sokolenko AP; Bogdanova N; Kluzniak W; Preobrazhenskaya EV; Kuligina ES; Iyevleva AG; Aleksakhina SN; Mitiushkina NV; Gorodnova TV; Bessonov AA; Togo AV; Lubiński J; Cybulski C; Jakubowska A; Dörk T; Imyanitov EN
    Breast Cancer Res Treat; 2014 Jun; 145(2):553-62. PubMed ID: 24800916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant BLM cytoplasmic expression associates with DNA damage stress and hypersensitivity to DNA-damaging agents in colorectal cancer.
    Votino C; Laudanna C; Parcesepe P; Giordano G; Remo A; Manfrin E; Pancione M
    J Gastroenterol; 2017 Mar; 52(3):327-340. PubMed ID: 27169843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUTYH hotspot mutations in unselected colonoscopy patients.
    Casper M; Plotz G; Juengling B; Zeuzem S; Lammert F; Raedle J
    Colorectal Dis; 2012 May; 14(5):e238-44. PubMed ID: 22469480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel frameshift mutation in BLM gene associated with high sister chromatid exchanges (SCE) in heterozygous family members.
    Ben Salah G; Hadj Salem I; Masmoudi A; Kallabi F; Turki H; Fakhfakh F; Ayadi H; Kamoun H
    Mol Biol Rep; 2014 Nov; 41(11):7373-80. PubMed ID: 25129257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.